Menu
Our Story
Who We Are
Latest Updates
← Back to Latest Updates
Press Release
Diasome announces dosing of first type 1 diabetes patient in randomized phase 2b clinical trial of injectable hepatocyte direct vesicle (HDV) technology with insulin
July 29, 2016